Ryan Sobel

751 total citations
17 papers, 549 citations indexed

About

Ryan Sobel is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ryan Sobel has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Microbiology, 8 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Ryan Sobel's work include Reproductive tract infections research (13 papers), Nail Diseases and Treatments (6 papers) and Reproductive Health and Contraception (4 papers). Ryan Sobel is often cited by papers focused on Reproductive tract infections research (13 papers), Nail Diseases and Treatments (6 papers) and Reproductive Health and Contraception (4 papers). Ryan Sobel collaborates with scholars based in United States and China. Ryan Sobel's co-authors include Jack D. Sobel, Paul Nyirjesy, Qingzhao Yu, Mairi C. Noverr, Junko Yano, Paul L. Fidel, Katyna Borroto–Esoda, Nkechi Azie, David Angulo and J. D. Sobel and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Obstetrics and Gynecology and Obstetrics and Gynecology.

In The Last Decade

Ryan Sobel

15 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan Sobel United States	10	297	286	263	67	62	17	549
Sean G. Chadwick United States	9	168 0.6×	287 1.0×	265 1.0×	110 1.6×	49 0.8×	13	472
Olufunmilola Makanjuola Nigeria	8	138 0.5×	161 0.6×	144 0.5×	37 0.6×	30 0.5×	25	322
Yvonne Döerffel Germany	7	107 0.4×	161 0.6×	202 0.8×	498 7.4×	88 1.4×	12	756
Jean-Pierre Lepargneur France	12	228 0.8×	203 0.7×	31 0.1×	148 2.2×	22 0.4×	20	431
Samantha Seidor United States	12	240 0.8×	141 0.5×	236 0.9×	36 0.5×	7 0.1×	13	462
Adama Zida Burkina Faso	9	52 0.2×	138 0.5×	186 0.7×	64 1.0×	11 0.2×	36	422
Kyoko Kawazoe Japan	12	85 0.3×	131 0.5×	61 0.2×	40 0.6×	19 0.3×	38	303
Veranja Liyanapathirana Sri Lanka	15	43 0.1×	124 0.4×	109 0.4×	60 0.9×	7 0.1×	45	458
Rémi Le Guern France	14	58 0.2×	134 0.5×	183 0.7×	144 2.1×	12 0.2×	34	503
Varsha Moudgal United States	9	28 0.1×	316 1.1×	398 1.5×	166 2.5×	15 0.2×	18	649

Countries citing papers authored by Ryan Sobel

Since Specialization

Citations

This map shows the geographic impact of Ryan Sobel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Sobel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Sobel more than expected).

Fields of papers citing papers by Ryan Sobel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Sobel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Sobel. The network helps show where Ryan Sobel may publish in the future.

Co-authorship network of co-authors of Ryan Sobel

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Sobel. A scholar is included among the top collaborators of Ryan Sobel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Sobel. Ryan Sobel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sobel, Ryan, et al.. (2025). Patterns of Intravaginal Boric Acid and Probiotics Use Among Patients With Chronic Vulvovaginal Symptoms. Journal of Lower Genital Tract Disease. 30(1). 71–75.

Azie, Nkechi, et al.. (2025). A phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology. 233(6). 617.e1–617.e18. 1 indexed citations

Lederman, Samuel, et al.. (2025). Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis. Journal of Women s Health. 35(3). 334–339.

Sobel, Ryan, et al.. (2023). Vulvovaginal Candidiasis in Postmenopausal Women. Current Infectious Disease Reports. 25(4). 61–66. 5 indexed citations

Sobel, Ryan, et al.. (2023). Fluconazole-Resistant Candida albicans Vaginal Infections at a Referral Center and Treated With Boric Acid. Journal of Lower Genital Tract Disease. 27(3). 262–265. 13 indexed citations

Sobel, Ryan, et al.. (2023). Topical Therapy for Vulvodynia: A Review of the Literature. 43(1). 1–11. 1 indexed citations

Sobel, Ryan, Paul Nyirjesy, Steven R. Goldstein, et al.. (2022). Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306. Journal of Women s Health. 32(2). 178–186. 18 indexed citations

Schwebke, Jane R., Ryan Sobel, Janet Gersten, et al.. (2021). Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clinical Infectious Diseases. 74(11). 1979–1985. 62 indexed citations

Sobel, Ryan, et al.. (2021). Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306). BJOG An International Journal of Obstetrics & Gynaecology. 129(3). 412–420. 41 indexed citations

10.

Sobel, Jack D. & Ryan Sobel. (2021). Current and emerging pharmacotherapy for recurrent bacterial vaginosis. Expert Opinion on Pharmacotherapy. 22(12). 1593–1600. 15 indexed citations

11.

Sobel, Ryan, et al.. (2020). Fluconazole Prophylaxis in Prevention of Symptomatic Candida Vaginitis. Current Infectious Disease Reports. 22(1). 2–2. 11 indexed citations

12.

Barat, Stephen, et al.. (2019). Ibrexafungerp, a Novel Oral Antifungal, Demonstrates No Reproductive or Developmental Harm in Preclinical Models [25J]. Obstetrics and Gynecology. 133(1). 114S–114S. 2 indexed citations

13.

Yano, Junko, Jack D. Sobel, Paul Nyirjesy, et al.. (2019). Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women s Health. 19(1). 48–48. 176 indexed citations

14.

Sobel, Jack D. & Ryan Sobel. (2018). Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opinion on Pharmacotherapy. 19(9). 971–977. 130 indexed citations

15.

Chavoustie, Steven, Scott Evan Eder, William Koltun, et al.. (2017). Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers. International Journal of Gynecology & Obstetrics. 137(2). 107–109. 18 indexed citations

16.

Sobel, Ryan & Jack D. Sobel. (2015). Metronidazole for the treatment of vaginal infections. Expert Opinion on Pharmacotherapy. 16(7). 1109–1115. 51 indexed citations

17.

Jayaram, Aswathi, et al.. (2014). Decreased concentration of protease inhibitors: possible contributors to allodynia and hyperalgesia in women with vestibulodynia. American Journal of Obstetrics and Gynecology. 212(2). 184.e1–184.e4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact